Skip to main content
. 2017 Nov 30;7:16609. doi: 10.1038/s41598-017-16924-y

Table 1.

Characteristics of the study participants.

Variables Male (n = 1813) Female (n = 1858)
No sarcopenia (n = 335) Class I sarcopenia (n = 1121) Class II sarcopenia (n = 357) P value No sarcopenia (n = 1046) Class I sarcopenia (n = 536) Class II sarcopenia (n = 276) P value
Continuous variables
Age (years), mean (SD) 68.02 (6.69) 70.77 (7.72) 73.35 (8.15) <0.001 70 (7.17) 73.35 (8.43) 74.04 (8.53) <0.001
Platelet-lymphocyte ratio, mean (SD) 116.39 (40.75) 127.24 (54.64) 136.08 (58.46) <0.001 125.14 (44.43) 140.12 (54.83) 147.16 (61.42) <0.001
Neutrophil-lymphocyte ratio, mean (SD) 2.18 (1.22) 2.29 (1.59) 2.52 (1.41) 0.196 2.09 (1.27) 2.24 (1.24) 2.33 (1.58) 0.277
C-reactive protein (mg/dL), mean (SD) 0.53 (0.86) 0.5 (0.92) 0.61 (0.96) 0.165 0.63 (1.06) 0.56 (1.13) 0.55 (0.917) 0.361
Plasma fibrinogen (mg/dL), mean (IQR) 576.1 (87) 569.1 (94) 670.6 (118) 0.521 519.6 (100) 666.47 (101) 643.7 (129) 0.115
Serum uric acid (mg/dL), mean (SD) 6.18 (1.38) 6.09 (1.41) 6.02 (1.43) 0.319 5.43 (1.49) 5.02 (1.34) 5.21 (1.58) <0.001
Serum bilirubin (mg/dL), mean (SD) 0.64 (0.25) 0.68 (0.33) 0.65 (0.29) 0.057 0.52 (0.26) 0.52 (0.26) 0.49 (0.17) 0.124
Categorical variables
Non-Hispanic white, n (%) 176 (52.5) 654 (58.3) 198 (55.5) 0.623 597 (57.1) 350 (65.3) 162 (58.7) 0.058
Coronary heart disease, n (%) 40 (11.9) 143 (12.8) 46 (12.9) 0.459 76 (7.3) 36 (6.7) 20 (7.2) 0.099
Stroke, n (%) 20 (6) 58 (5.2) 28 (7.8) 0.054 55 (5.4) 27 (5.1) 29 (10.6) 0.006
Metabolic syndrome, n (%) 217 (64.8) 546 (48.7) 145 (40.6) <0.001 746 (71.3) 284 (53) 139 (50.4) <0.001
Alcohol drinking, n (%) 96 (59.3) 268 (50.9) 83 (52.5) 0.062 266 (57.3) 140 (57.6) 67 (54.5) 0.954
Smoking, n (%) 41 (17.5) 211 (26.4) 91 (35.3) <0.001 110 (30.2) 76 (39.2) 45 (43.3) 0.016